XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
IPO
Private placement
Common Stock
Common Stock
IPO
Common Stock
Private placement
Additional Paid‑In Capital
Additional Paid‑In Capital
IPO
Additional Paid‑In Capital
Private placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018       102,649,701              
Beginning balance at Dec. 31, 2018 $ 531,683     $ 103     $ 565,372     $ 0 $ (33,792)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares)       168,391              
Exercise of stock options 923     $ 0     923        
Vesting of restricted stock units (in shares)       25,520              
Share‑based compensation 2,461           2,461        
Foreign currency translation adjustments 0                    
Net loss (34,345)                   (34,345)
Ending balance (in shares) at Dec. 31, 2019       102,843,612              
Ending balance at Dec. 31, 2019 500,722     $ 103     568,756     0 (68,137)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares)       526,460              
Exercise of stock options 2,985           2,985        
Issuance of common stock (in shares)         13,500,000 85,880          
Issuance of common stock   $ 322,413 $ 2,233   $ 14     $ 322,399 $ 2,233    
Vesting of restricted stock units (in shares)       36,520              
Share‑based compensation 6,743           6,743        
Foreign currency translation adjustments 0                    
Net loss (24,082)                   (24,082)
Ending balance (in shares) at Dec. 31, 2020       116,992,472              
Ending balance at Dec. 31, 2020 811,014     $ 117     903,116     0 (92,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares)       1,903,560              
Exercise of stock options 10,691     $ 1     10,690        
Vesting of restricted stock units (in shares)       530,032              
Vesting of restricted stock units 1     $ 1              
Share‑based compensation 35,805           35,805        
Purchase of capped calls (36,030)           (36,030)        
Foreign currency translation adjustments (7,866)                 (7,866)  
Net loss (75,189)                   (75,189)
Ending balance (in shares) at Dec. 31, 2021       119,426,064              
Ending balance at Dec. 31, 2021 $ 738,426     $ 119     $ 913,581     $ (7,866) $ (167,408)